Madrigal Pharmaceuticals
Trade Madrigal Pharmaceuticals 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About MDGL
Madrigal Pharmaceuticals, Inc. engages in the development and commercialization of innovative therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product, MGL-3196, is used for the treatment of non-alcoholic steatohepatitis and familial hypercholesterolemia.
MDGL Key Statistics
Stock Snapshot
As of today, Madrigal Pharmaceuticals(MDGL) shares are valued at $554.57. The company's market cap stands at 12.6B, with a P/E ratio of -42.63.
On 2025-12-17, Madrigal Pharmaceuticals(MDGL) stock traded between a low of $544.24 and a high of $560.00. Shares are currently priced at $554.57, which is +1.9% above the low and -1.0% below the high.
The Madrigal Pharmaceuticals(MDGL)'s current trading volume is 267.26K, compared to an average daily volume of 262.88K.
During the past year, Madrigal Pharmaceuticals(MDGL) stock moved between $265.00 at its lowest and $605.00 at its peak.
During the past year, Madrigal Pharmaceuticals(MDGL) stock moved between $265.00 at its lowest and $605.00 at its peak.
MDGL News
Madrigal Pharmaceuticals recently appointed industry veteran Rita Thakkar as Senior Vice President and Chief Accounting Officer, while continuing to expand comm...
